(Q45239690)

English

Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease

scientific article published in December 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Katsuya Satoh

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Susumu Shirabe

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Katsumi Eguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Atsushi Yamauchi

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Yasufumi Kataoka

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Masami Niwa

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Noriyuki Nishida

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Shigeru Katamine

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Cellular and Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

873-875

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/15672687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15672687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15672687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15672687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of quinacrine (mepacrine) in plasma by high-performance liquid chromatography with fluorimetric detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15672687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10571-004-6926-7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45239690&oldid=2207166164"